GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Wuhan Keqian Biology Co Ltd (SHSE:688526) » Definitions » EV-to-FCF

Wuhan Keqian Biology Co (SHSE:688526) EV-to-FCF : 14.46 (As of Jun. 23, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Wuhan Keqian Biology Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Wuhan Keqian Biology Co's Enterprise Value is ¥5,759.0 Mil. Wuhan Keqian Biology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was ¥398.3 Mil. Therefore, Wuhan Keqian Biology Co's EV-to-FCF for today is 14.46.

The historical rank and industry rank for Wuhan Keqian Biology Co's EV-to-FCF or its related term are showing as below:

SHSE:688526' s EV-to-FCF Range Over the Past 10 Years
Min: 13.58   Med: 43.67   Max: 128.22
Current: 14.87

During the past 8 years, the highest EV-to-FCF of Wuhan Keqian Biology Co was 128.22. The lowest was 13.58. And the median was 43.67.

SHSE:688526's EV-to-FCF is ranked worse than
61.69% of 402 companies
in the Biotechnology industry
Industry Median: 5.935 vs SHSE:688526: 14.87

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-23), Wuhan Keqian Biology Co's stock price is ¥15.15. Wuhan Keqian Biology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.740. Therefore, Wuhan Keqian Biology Co's PE Ratio for today is 20.47.


Wuhan Keqian Biology Co EV-to-FCF Historical Data

The historical data trend for Wuhan Keqian Biology Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuhan Keqian Biology Co EV-to-FCF Chart

Wuhan Keqian Biology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial - 59.68 77.25 29.90 19.54

Wuhan Keqian Biology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.82 27.29 18.71 19.54 17.18

Competitive Comparison of Wuhan Keqian Biology Co's EV-to-FCF

For the Biotechnology subindustry, Wuhan Keqian Biology Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wuhan Keqian Biology Co's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Wuhan Keqian Biology Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Wuhan Keqian Biology Co's EV-to-FCF falls into.



Wuhan Keqian Biology Co EV-to-FCF Calculation

Wuhan Keqian Biology Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=5758.967/398.307
=14.46

Wuhan Keqian Biology Co's current Enterprise Value is ¥5,759.0 Mil.
Wuhan Keqian Biology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥398.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wuhan Keqian Biology Co  (SHSE:688526) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Wuhan Keqian Biology Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=15.15/0.740
=20.47

Wuhan Keqian Biology Co's share price for today is ¥15.15.
Wuhan Keqian Biology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.740.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Wuhan Keqian Biology Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Wuhan Keqian Biology Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Wuhan Keqian Biology Co (SHSE:688526) Business Description

Traded in Other Exchanges
N/A
Address
No. 419, Gaoxin 2nd Road, Donghu New Technology Development Zone, Hubei Province, Wuhan, CHN, 430073
Wuhan Keqian Biology Co Ltd is engaged in research and development, production, sales and animal epidemic prevention technical services of veterinary biological products. The company's products include Combination plan; Vaccine for swine; Poultry vaccine; Pet vaccine; and Diagnostic reagent.
Executives
Hao Gen Xi Core technical personnel
Zhang Hua Wei Core technical personnel
Zhou Ming Guang Core technical personnel
Zou Tian Tian senior management
Xu Gao Yuan Director
Chen Guan Ping Director

Wuhan Keqian Biology Co (SHSE:688526) Headlines

No Headlines